| 30 April 2011
|
|
|
|
|
| |
|
|
|
12:00 20:00
|
|
Registration
|
| |
|
|
|
15:00 17:00
|
|
Satellite Symposium: Growth hormone: less and in excess
Sponsored by Sandoz
Willem Burger Auditorium
Chairs: G. Stalla & M. Pfeifer
|
| 15:00 |
|
Welcome
G. Stalla & M. Pfeifer
|
| 15:10 |
|
Metabolic consequences of growth hormone deficiences
P. Chanson
|
| 15:35 |
|
Different causes of pituitary insufficiency
G. Aimaretti
|
| 16:00 |
|
More than a decade of growth hormone substitution: what have we learnt?
S. Shalet
|
| 16:25 |
|
Growth hormone abuse
M. Bidlingmeier
|
| 16:50 |
|
Closing remarks
|
| |
|
|
|
17:30 18:05
|
|
Opening Ceremony: Welcome & Introduction
Main Auditorium
Chair: E. Nieschlag (Germany)
|
| 17:30 |
|
Introduction & Welcome to ECE 2011
E. Nieschlag (Germany)
|
| 17:45 |
|
Welcome to Rotterdam & ECE 2011
P. Trainer (UK) & W. de Herder (The Netherlands)
|
| |
|
|
|
18:05 18:45
|
|
Opening Ceremony: Geoffrey Harris Prize Lecture
Main Auditorium
Chair: B. Jarzab (Poland)
|
| 18:10 |
GH1
|
GHRELIN: a neuroendocrine and/or metabolic story?
E. Ghigo (Italy)
|
| |
|
|
|
18:45 19:30
|
|
Opening Ceremony: European Journal of Endocrinology Prize Lecture
Main Auditorium
Chair: C. Strasburger - Editor-in-Chief of EJE (Germany)
|
| |
|
|
|
19:30 21:00
|
|
ECE 2011 Welcome Reception
Exhibition Hall
|
| |
|
|
|
21:30
|
|
|
| |
|
|
| 1 May 2011
|
|
06:30 20:00
|
|
Registration
|
| |
|
|
|
06:45 07:50
|
|
Handbook of Cushing's Disease Book Launch
Generously supported by Novartis
Willem Burger Auditorium
|
| 06:45 |
|
Breakfast reception
|
| 07:15 |
|
Welcome & Introduction
SWJ Lamberts
|
| 07:25 |
|
Different treatment options, which and when? What does the future hold?
R. Pivonello
|
| 07:40 |
|
Q&A and book distribution
|
| |
|
|
|
08:00 08:45
|
|
Plenary Lecture 1
Main Auditorium
Chair: P. Beck - Peccoz
|
| 08:00 |
PL1
|
Disorders of sex development (DSD)
T. Ogato (Japan)
|
| |
|
|
|
08:45 09:00
|
|
Presidential Address
Main Auditorium
|
| |
|
|
|
09:05 10:35
|
|
Symposium 1: Keep cool, lose weight: brown fat and energy metabolism
Willem Burger Auditorium
Chairs: J. Romijn (The Netherlands) & U. Pagotto (Italy)
|
| 09:05 |
S1.1
|
Brown adipocytes and energy homeostasis in mice
S. Herzig (Germany)
|
| 09:35 |
S1.2
|
Physiology of brown adipose tissue in humans
P. Nuutila (Finland)
|
| 10:05 |
S1.3
|
Brown adipose tissue and thermogenesis in lean and obese subjects
W. van Marken (The Netherlands)
|
| |
|
|
|
09:05 10:35
|
|
Symposium 2: Controversies in hyperaldosteronism
Main Auditorium
Chairs: M. Coculescu (Romania) & P. Stewart (UK)
|
| 09:05 |
S2.1
|
Controversies in hyperaldosteronism: whom and how to screen
P. Mulatero (Italy)
|
| 09:35 |
S2.2
|
Adrenal vein sampling
T. Zelinka (Czech Republic)
|
| 10:05 |
S3.3
|
Non surgical therapy of primary aldosteronism
M. Stowasser (Australia)
|
| |
|
|
|
09:05 10:35
|
|
Symposium 3: Molecular mechanisms in neuroendocrine tumours
Fortis Bank Hall
Chairs: L. Hofland (The Netherlands) & J. Castano (Spain)
|
| 09:05 |
S3.1
|
Somatostatin and dopamine signalling in neuroendocrine tumours
D. Ferone (Italy)
|
| 09:35 |
S3.2
|
A new truncated variant of somatostatin receptor subtype five, sst5TMD4, is present in pituitary tumours and breast cancer, and impairs the normal response to somatostatin
J. Castano (Spain)
|
| 10:05 |
S3.3
|
Lessons from MENX
N. Pellegata (Germany)
|
| |
|
|
|
09:05 10:35
|
|
Symposium 4: Subclinical hormone excess
Jurriaanse Auditorium
Chairs: W. Wiersinga (The Netherlands) & M. Terzolo (Italy)
|
| 09:05 |
S4.1
|
Subclinical adrenal hyperfunction
G. Kaltas (Greece)
|
| 09:35 |
S4.2
|
Normocalcemic primary hyperparathyroidism
F. Cetani (Italy)
|
| 10:05 |
S4.3
|
Subclinical hyperthyroidism
B. Biondi (Italy)
|
| |
|
|
|
10:35 11:00
|
|
Coffee Break & Exhibition
Exhibition Hall
|
| |
|
|
|
11:00 12:00
|
|
Debate 1: This house believes that far too few post-menopausal women receive oestrogen therapy
For: J. Studd (London); Against: J Foidart (Belgium)
Main Auditorium
Chair: P. Bouchard
France
|
| |
|
|
|
11:00 11:45
|
|
Meet the Expert 1
Willem Burger Auditorium
|
| 11:00 |
MTE1
|
Pros and cons of bariatric surgery
J. Salvador (Spain)
|
| |
|
|
|
11:00 11:45
|
|
Meet the Expert 2
Jurriaanse Auditorium
|
| 11:00 |
MTE2
|
Primary hyperaldosteronism
M. Stowasser (Australia)
|
| |
|
|
|
11:00 11:45
|
|
Meet the Expert 3
Fortis Bank Hall
|
| 11:00 |
MTE3
|
Difficult recurrences and metastasis of thyroid cancer
L. Leenhardt (France)
|
| |
|
|
|
11:00 11:45
|
|
Meet the Expert 4
Van Ruckevorsal Hall
|
| 11:00 |
MTE4
|
Mass spectrometry in the measurement of hormones
U. Pagotto (Italy)
|
| |
|
|
|
11:00 11:45
|
|
Meet the Expert 5
Van der Vorm Hall
|
| 11:00 |
MTE5
|
How to write a manuscript - Meet the Editor
C. Strasburger (Germany)
|
| |
|
|
|
12:00 12:40
|
|
Lunch & Exhibition
ESE President meets ESE Affiliated Society Presidents (invitation only)
Exhibition Hall
|
| |
|
|
|
12:40 14:10
|
|
Symposium 5: Novel therapies in type-1 diabetes
Willem Burger Auditorium
Chairs: J. Skrha (Czech Republic) & J. Christiansen (Denmark)
|
| 12:40 |
S5.1
|
Pancreas transplantation
T. Berney (Switzerland)
|
| 13:10 |
S5.2
|
Islet transplantation and regeneration
E. de Koning (NL)
|
| 13:40 |
S5.3
|
Stem cells as a treatment option in diabetes mellitus
J. Kerr-Conte (France)
|
| |
|
|
|
12:40 14:10
|
|
Symposium 6: Long term effects of bisphosphonates
Main Auditorium
Chairs: M. Bolanowski (Poland) & V. Rochira (Italy)
|
| 12:40 |
S6.1
|
The risk of fractures and osteonecrosis
B. Abrahamsen (Denmark)
|
| 13:10 |
S6.2
|
Long term management of osteoporosis
E. Eriksen (Norway)
|
| 13:40 |
S6.3
|
Bone turnover markers in the management of osteoporosis
M. Seibel (Australia)
|
| |
|
|
|
12:40 14:10
|
|
Symposium 7: Novel approaches to in vitro and in vivo imaging
Fortis Bank Hall
Chairs: TBC & W. Arlt (UK)
|
| 12:40 |
S7.1
|
How to visualize G-protein coupled receptor signaling by FRET
D. Calebiro (Germany)
|
| 13:10 |
S7.2
|
Multiphoton microscopy to visualize cell migration and invasion
K. Wolf (The Netherlands)
|
| 13:40 |
S7.3
|
Molecular and clinical imaging of adrenal steroidogenesis by iodometomidate
S. Hahner (Germany)
|
| |
|
|
|
12:40 14:10
|
|
Symposium 8: The biological clock and metabolism
Jurriaanse Auditorium
Chairs: S. La Fleur (The Netherlands) & TBC
|
| 12:40 |
S8.1
|
Clock genes in human adipose tissue
M. Garaulet (Spain)
|
| 13:10 |
S8.2
|
Circadian clock regulation of glucocorticoid synthesis
H. Oster (Germany)
|
| 13:40 |
S8.3
|
Feeding the clock
J. Johnston (UK)
|
| |
|
|
|
14:15 15:00
|
|
Meet the Expert 6
Willem Burger Auditorium
|
| 14:45 |
MTE6
|
Difficult adrenal cases
W. Young (USA)
|
| |
|
|
|
14:15 15:00
|
|
Meet the Expert 7
Jurriaanse Auditorium
|
| 14:45 |
MTE7
|
When to instigate insulin therapy in DM2
J. Skrha (Czech Republic)
|
| |
|
|
|
14:15 15:00
|
|
Meet the Expert 8
Fortis Bank Hall
|
| 14:45 |
MTE8
|
Management of primary ovarian failure
L. Persani (Italy)
|
| |
|
|
|
14:15 15:00
|
|
Meet the Expert 9
Eduard Flipse Hall
|
| 14:45 |
MTE9
|
Pleiotropic effects of Vitamin D
M. Pfeifer (Slovenia)
|
| |
|
|
|
14:15 15:00
|
|
Meet the Expert 10
Van Ruckevorsal Hall
|
| 14:45 |
MTE10
|
Biomarkers of thyroid malignancy
M. Sobrinho-simoes (Portugal)
|
| |
|
|
|
14:15 15:00
|
|
Meet the Expert 11
Van der Vorm Hall
|
| 14:45 |
MTE11
|
Prolactin and breast tumorogesis: a novel concept of prolactin biology
P. Touraine (France)
|
| |
|
|
|
15:00 15:20
|
|
Coffee Break & Exhibition
Exhibition Hall
|
| |
|
|
|
15:20 16:50
|
|
Symposium 9: New endocrine aspects of diabetes mellitus
Main Auditorium
Chairs: J. Christiansen (Denmark) & A. Scheurink (The Netherlands)
|
| 15:20 |
S9.1
|
The incretin system: from discovery to drug development
T. Vilsboll (Denmark )
|
| 15:50 |
S9.2
|
GLP-1 and the cardiovascular system
M. Diamant (The Netherlands)
|
| 16:20 |
S9.3
|
GLP-1 biology: beyond the pancreas
D. Sandoval (USA)
|
| |
|
|
|
15:20 16:50
|
|
Symposium 10: New developments in the therapy for NETs
Willem Burger Auditorium
Chairs: B. Kos-Kudla (Poland) & G. Kaltsas (Greece)
|
| 15:20 |
S10.1
|
New developments in the therapy for NETs: risk stratification
M. Pavel (Germany)
|
| 15:50 |
S10.2
|
Peptide receptor targeted radiotherapy
D. Kwekkeboom (NL )
|
| 16:20 |
S10.3
|
New drugs including mTOR inhibitors
S. Grozinksky-Glasberg (Israel)
|
| |
|
|
|
15:20 16:50
|
|
Symposium 11: Genetics of male infertility
Fortis Bank Hall
Chairs: M. Maggi (Italy) & P. Touraine (France)
|
| 15:20 |
S11.1
|
Update on genetics in male infertility
A. Ferlin (Italy )
|
| 15:50 |
S11.2
|
Clinical aspects of Klinefelter syndrome in childhood, adolescence and adulthood
A. Juul (Denmark)
|
| 16:20 |
S11.3
|
Genomics of azoospermia
F. Tuttelmann (Germany )
|
| |
|
|
|
15:20 16:05
|
|
Meet the Expert 23
Van Ruckevorsal Hall
|
| 15:20 |
MTE23
|
Transgenic animals in endocrinology
M. Poutanen (Finland)
|
| |
|
|
|
16:05 16:50
|
|
Meet the Expert 24
Van der Vorm Hall
|
| 16:05 |
MTE24
|
Stem Cell Biology
C. Alvarez (Spain)
|
| |
|
|
|
16:55 17:40
|
|
Plenary Lecture 2
Main Auditorium
Chair: T. Visser
|
| 16:55 |
PL2
|
Making sense with thyroid hormone
D. Forrest (USA)
|
| |
|
|
|
17:40 18:30
|
|
Poster Reception
Poster Halls
|
| |
|
|
|
18:30 20:00
|
|
Satellite Symposium: Somatostatin analogues development: what do we learn from recent studies?
Sponsored by Ipsen
Willem Burger Auditorium
Chairs: S. Lambers (The Netherlands) & S. Webb (Spain)
|
| 18:30 |
|
Approaches to acromegaly treatment resistance
S. Melmed
|
| 18:50 |
|
A critical analysis of co-administration pegvisomant/somatostatin analogues
D. Ferone (Italy)
|
| 19:10 |
|
Treatment of polycystic liver disease
F. Nevens (Belgium)
|
| 19:30 |
|
Mode of administration: clinical importance of injection device and nurse preference
P. Kamenicky (France)
|
| |
|
|
|
18:30 20:00
|
|
Satellite Symposium: Uncovering the intricacies of water and electrolyte balance in Hyponatraemia due to SIADH
Spnsored by Otsuka
Jurriaanse Auditorium
Chair: C. Thompson
|
| 18:30 |
|
Welcome & Introduction
C. Thompson
|
| 18:35 |
|
Uncovering the intricacies of water and electrolyte balance in hyponatraemia due to SIADH
R. Schrier
|
| 19:00 |
|
Considerations for the appropriate diagnosis and treatment of hyponatraemia due to SIADH
C. Thompson
|
| 19:25 |
|
Clinical application of treatment considerations: Case example
A. Peri
|
| 19:50 |
|
Questions and answers
|
| |
|
|
|
18:30 20:00
|
|
Satellite Symposium: 5 years and counting: insights from ACROSTUDY
Sponsored by Pfizer
Main Auditorium
Chair: E. Ghigo (Italy)
|
| 18:30 |
|
Introduction and study overview
E. Ghigo (Italy)
|
| 18:55 |
|
Pegvisomant: long-term clinical outcomes
C. Strasburger (Germany)
|
| 19:15 |
|
Safety observations from the treatment of acromegaly
AJ van der Lely (The Netherlands)
|
| 19:35 |
|
Tumour volume change: central anaylsis of MRIs in ACROSTUDY
M. Buchfelder (Germany)
|
| 19:40 |
|
Summary & Q&A
|
| |
|
|
|
20:30 00:00
|
|
ECE 25th Anniversary Evening (Ticket Only)
Transport will be provided
Cruise Terminal, Rotterdam
|
| |
|
|
| 2 May 2011
|
|
07:00 20:00
|
|
Registration
|
| |
|
|
|
08:00 08:45
|
|
Plenary Lecture 3
Main Auditorium
Chair: S. Lamberts
|
| 08:00 |
PL3
|
Targets for the management of diabetes in 2011
J. Christiansen (Denmark )
|
| |
|
|
|
08:50 10:20
|
|
Symposium 12: Novel insights into phosphate metabolism
Main Auditorium
Chairs: N. Hamdy (The Netherlands) & J. Bollerslev (Norway)
|
| 08:50 |
S12.1
|
The maintenance of phosphate homeostasis by FGF23
O. Ljunggren (Sweden)
|
| 09:20 |
S12.2
|
Genetic disorders of phosphate metabolism
G. Hampson (UK)
|
| 09:50 |
S12.3
|
FGF23: marker or predictor of progression in chronic kidney disease
D. Prie (France)
|
| |
|
|
|
08:50 10:20
|
|
Oral Communication 1
Jurriaanse Auditorium
Chairs: D. Carvalho (Portugal) & M. Niedziela (Poland)
|
| 08:50 |
OC1.1
|
Maternal first trimester thyroid hormone levels within the normal range affect birth weight: results from a large population-based cohort study
Presenter: M Medici
|
| 09:05 |
OC1.2
|
Smoking habits and early pregnancy thyroid hormone and antibody levels
Presenter: T Männistö
|
| 09:20 |
OC1.3
|
Maternal thyroid dysfunction during pregnancy and thyroid function of the offspring at the age of 16 years
Presenter: Fanni Päkkilä
|
| 09:35 |
OC1.4
|
Results of 1,Ortho-1,para’-Dichloro-Diphenyl-Dichloroethane (O,p’DDD) treatment in 76 patients with Cushing’s Disease
Presenter: C. Baudry
|
| 09:50 |
OC1.5
|
Adrenal crisis and general morbidity in chronic adrenal insufficiency prospectively assessed in 472 patients
Presenter: Stefanie Hahner
|
| 10:05 |
OC1.6
|
Increased risk of infections in patients with Addison’s disease
Presenter: l.c.c.j. Smans
|
| |
|
|
|
08:50 10:20
|
|
Oral Communication 2
Eduard Flipse Hall
Chairs: P. Burman (Sweden) & AJ van der Lely (The Netherlands)
|
| 08:50 |
OC2.1
|
Etoposide, doxorubicin, cisplatin, and mitotane versus streptozotocin and mitotane in adrenocortical carcinoma – preliminary results from the first international phase III trial - the FIRM-ACT study
Presenter: Martin Fassnacht
|
| 09:05 |
OC2.2
|
Gonadotropin responses to kisspeptin are modulated by changes in aminoacidergic and neuropeptidergic neurotransmission: Studies in peripubertal male rats
Presenter: R. Pineda
|
| 09:20 |
OC2.3
|
Distribution of serotonin transporters in the human hypothalamus
Presenter: A.J. Borgers
|
| 09:35 |
OC2.4
|
Genetic and molecular cytogenetic investigations in Turner Syndrome patients with spontaneous pubertal development
Presenter: R Rossetti
|
| 09:50 |
OC2.5
|
Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson’s disease and hyperprolactinemia
Presenter: G Trifirò
|
| 10:05 |
OC2.6
|
The spectrum and causes of gonadal dysfunction in adolescents and adults with Prader-Willi Syndrome (PWS)
Presenter: Talia Eldar-Geva
|
| |
|
|
|
10:20 10:40
|
|
Coffee Break & Exhibition
Exhibition Hall
|
| |
|
|
|
10:40 11:40
|
|
Debate 2: This house believes the future management of all pituitary adenomas will be medical
For: S. Lamberts. Against: R. Fahlbusch
Main Auditorium
Chair: P. Trainer (UK)
|
| |
|
|
|
10:40 11:25
|
|
Meet the Expert 12
Willem Burger Auditorium
|
| 10:40 |
MTE12
|
Treatment of strategies for obesity
D. Micic (Serbia)
|
| |
|
|
|
10:40 11:25
|
|
Meet the Expert 13
Jurriaanse Auditorium
|
| 10:40 |
MTE13
|
SIADH
C. Thompson (Ireland)
|
| |
|
|
|
10:40 11:25
|
|
Meet the Expert 14
Fortis Bank Hall
|
| 10:40 |
MTE14
|
Graves’ Ophthalmopathy
W. Wiersinga (The Netherlands)
|
| |
|
|
|
10:40 11:25
|
|
Meet the Expert 15
Van der Vorm Hall
|
| 10:40 |
MTE15
|
Cushing's
S. Webb (Spain)
|
| |
|
|
|
10:40 11:25
|
|
Meet the Expert 16
Van Ruckevorsal Hall
|
| 10:40 |
MTE16
|
Endocrine care in HIV-infected patients
V. Rochira (Italy)
|
| |
|
|
|
11:45 13:15
|
|
Symposium 13: Endocrine response to critical illness
Willem Burger Auditorium
Chairs: E. Fliers (The Netherlands) & I. Lazurova (Slovakia)
|
| 11:45 |
S13.1
|
The HPA axis in critical illness
D. Annane (France )
|
| 12:15 |
S13.2
|
Thyroid hormone metabolism in inflammation and sepsis
A. Boelen (NL )
|
| 12:45 |
S13.3
|
Novel insights in endocrine and metabolic changes during critical illness
G. van den Berge (Belgium )
|
| |
|
|
|
11:45 13:15
|
|
Symposium 14: Female contraception update
Jurriaanse Auditorium
Chairs: S. Christin-Maitre (France) & A. Milewicz (Poland)
|
| 11:45 |
S14.1
|
Compliance and the risk of pregnancy
A. Glasier (UK)
|
| 12:15 |
S14.2
|
New pills
R. Sitruk-Ware (USA)
|
| 12:45 |
S14.3
|
Emergency Contraception
K. Gemzell-Danielsson (Sweden )
|
| |
|
|
|
11:45 13:15
|
|
Symposium 15: Emerging therapies in type 2 diabetes
Main Auditorium
Chairs: B. Wolffenbuttel (The Netherlands) & I. Konrade (Latvia)
|
| 11:45 |
S15.1
|
Emerging therapies in type 2 diabetes: bariatric surgery
H. Cardoso (Portugal )
|
| 12:15 |
S15.2
|
11 beta Hydrooxysteroid dehaydrogenase inhibitors for treatment of metabolic syndrome
P. Stewart (UK )
|
| 12:45 |
S15.3
|
Future therapies - what is in the pipeline?
S. S. Torekov (Denmark)
|
| |
|
|
|
11:45 12:30
|
|
Meet the Expert 24 (REPEATED)
Van der Vorm Hall
|
| 11:45 |
MTE24
|
Stem Cell Biology
C. Alvarez (Spain)
|
| |
|
|
|
12:30 13:15
|
|
Meet the Expert 23 (REPEATED)
Van Ruckevorsal Hall
|
| 12:30 |
MTE23
|
Transgenic animals in endocrinology
M. Poutanen (Finland)
|
| |
|
|
|
13:15 14:00
|
|
Lunch & Exhibition
ESE President meets new members of ESE (invitation only)
Exhibition Hall
|
| |
|
|
|
14:00 14:45
|
|
Meet the Expert 6 (REPEATED)
Willem Burger Auditorium
|
| 14:00 |
MTE6
|
Difficult adrenal cases
W. Young (USA)
|
| |
|
|
|
14:00 14:45
|
|
Meet the Expert 18
Jurriaanse Auditorium
|
| 14:00 |
MTE18
|
Weird thyroid function tests
M. Gurnell (UK)
|
| |
|
|
|
14:00 14:45
|
|
Meet the Expert 19
Fortis Bank Hall
|
| 14:00 |
MTE19
|
Management of primary hyperparathyroidism
J. Bollerslev (Norway)
|
| |
|
|
|
14:00 14:45
|
|
Meet the Expert 20
Eduard Flipse Hall
|
| 14:00 |
MTE20
|
Glucocorticoid replacement therapy
K. Lovas (Norway)
|
| |
|
|
|
14:00 14:45
|
|
Meet the Expert 21
Van Ruckevorsal Hall
|
| 14:00 |
MTE21
|
To whom to offer genetic analysis in patients with pituitary adenoma
A. Beckers (Belgium)
|
| |
|
|
|
14:00 14:45
|
|
Meet the Expert 22
Van der Vorm Hall
|
| 14:00 |
MTE22
|
Diabetes and the genome. Any use for our patients?
A-M Wagner (Spain)
|
| |
|
|
|
14:50 16:20
|
|
Symposium 16: TSH Receptor and thyroid disorders
Willem Burger Auditorium
Chairs: J. Koehrle (Germany) & L. Persani (Italy)
|
| 14:50 |
S16.1
|
TSH receptor antibodies
J. Sanders (UK )
|
| 15:20 |
S16.2
|
Activating and inactivating TSH receptor mutations
R. Paschke (Germany )
|
| 15:50 |
S16.3
|
Small-molecule TSH receptor ligands
S. Neumann (USA )
|
| |
|
|
|
14:50 16:20
|
|
Symposium 17: Pituitary Update
Jurriaanse Auditorium
Chairs: J. Marek (Czech Republic) & R. Pivonello (Italy)
|
| 14:50 |
S17.1
|
Radiosurgery and radiotherapy of pituitary addenomas
F. Castinetti (France )
|
| 15:20 |
S17.2
|
Update on pituitary surgery 2011
J. Honegger (Germany )
|
| 15:50 |
S17.3
|
Pituitary late effects of radiotherapy for brain tumours
M. Bolanowski (Poland )
|
| |
|
|
|
14:50 16:20
|
|
Symposium 18: Management of endocrine disease in pregnancy
Main Auditorium
Chairs: P. Caron (France) & T. Rajasalu (Estonia)
|
| 14:50 |
S18.1
|
Type-1 diabetes and pregnancy
P. Damm (Denmark )
|
| 15:20 |
S18.2
|
Type-2 diabetes in pregnancy
E. Anastasiou (Greece)
|
| 15:50 |
S18.3
|
Thyroid autoimmunity in pregnancy
K. Poppe (Belgium )
|
| |
|
|
|
16:20 16:40
|
|
Coffee Break & Exhibition
Exhibition Hall
|
| |
|
|
|
16:40 16:55
|
|
JME Prize Presentation
Main Auditorium
|
| |
|
|
|
16:55 17:40
|
|
Plenary Lecture 4
Main Auditorium
Chair: A. Themmen
|
| 16:55 |
PL4
|
Gonadotrophin signaling in health and disease
I. Huhtaniemi (Finland )
|
| |
|
|
|
17:40 18:30
|
|
Poster Reception
Poster Halls
|
| |
|
|
|
18:30 20:00
|
|
Satellite Symposium: Meet the Experts - Practical considerations in hyponatraemia: An interactive case study session
Sponsored by Otsuka
Jurriaanse Auditorium
Chair: G. Johannsson
|
| 18:30 |
|
Welcome & Introduction
G. Johannsson
|
| 18:45 |
|
Case Study 1
A. Peri
|
| 19:10 |
|
Case Study 2
V. Burst
|
| 19:35 |
|
Questions & Answers
|
| |
|
|
|
18:30 20:00
|
|
Satellite Symposium: Cushing's Disease - the case for long-term follow up
Sponsored by Novartis
Main Auditorium
Chair: S. Lamberts (The Netherlands)
|
| 18:30 |
|
Welcome & Introduction
S. Lamberts (The Netherlands)
|
| 18:40 |
|
Cushing's Disease case by case
A. Tabarin (France)
|
| 19:00 |
|
Strategies for improving outcomes for the patient with Cushings disease
B. Biller (USA)
|
| 19:20 |
|
Maintaining glycemic control during medical treatment for Cushing's disease
R. Henry (USA)
|
| 19:40 |
|
Summary, panel discussion and concluding remarks
|
| |
|
|
|
18:30 20:00
|
|
Satellite Symposium: New insights in adrenal cortical carcinoma
Sponsored by HRA Pharma
Willem Burger Auditorium
Chairs: G. Hammer & X. Bertagna
|
| 18:30 |
|
Emerging prognosis markers for survival and progress in ACC classification
E. Baudin
|
| 19:00 |
|
Revisiting mitotane therapy
M. Terzolo
|
| 19:30 |
|
New data on the treatment of advanced ACC
HR Haak
|
| |
|
|
|
20:00 21:30
|
|
Endocrine Nurses' Networking Meeting
|
| |
|
|
| 3 May 2011
|
|
07:00 20:00
|
|
Registration
|
| |
|
|
|
08:00 08:45
|
|
Plenary Lecture 5
Main Auditorium
Chair: P. Trainer
|
| 08:00 |
PL5
|
Endocrine hypertension
W. Young (USA )
|
| |
|
|
|
08:50 10:20
|
|
Symposium 19: Management of endocrine disease in adolescence
Main Auditorium
Chairs: E. van den Akker (The Netherlands) & J. Cap (Czech Republic)
|
| 08:50 |
S19.1
|
Management of congenital adrenal hyperplasia (CAH) in adolescence
H. Claahsen-van der Grinten (NL)
|
| 09:20 |
S19.2
|
The challenges of managing childhood cancer survivors during adolescence
H. Gleeson (UK )
|
| 09:50 |
S19.3
|
Management of type-1 diabetes in adolescence
Z. Sumnik (Czech Republic )
|
| |
|
|
|
08:50 10:20
|
|
Oral Communication 3
Jurriaanse Auditorium
Chairs: G. Williams (UK) & M. Simoni (Italy)
|
| 08:50 |
OC3.1
|
Mild Hyponatremia as a Risk Factor for Fractures: The Rotterdam Study
Presenter: C Zillikens
|
| 09:05 |
OC3.2
|
Changes in serum magnesium levels during cinacalcet therapy for primary hyperparathyroidism
Presenter: V. Daraki
|
| 09:20 |
OC3.3
|
Evolution of Neurobehavioral and Cognitive Symptoms in Patients with Primary Hyperparathyroidism Belonging to the Swiss Primary Hyperparathyroidism Cohort
Presenter: A Trombetti
|
| 09:35 |
OC3.4
|
Low doses of bisphenol A promote human seminoma cell proliferation in vitro by activating PKA and PKG via the non classical membrane G protein-coupled estrogen receptor (GPER)
Presenter: P. Fénichel
|
| 09:50 |
OC3.5
|
IGF-I PROMOTES SURVIVAL OF MAST CELLS AND REGULATES THEIR NUMBER IN THE DEVELOPING MAMMARY GLAND
Presenter: P. Ameri
|
| 10:05 |
OC3.6
|
Materno-Fetal Cardiovascular Complications in Turner Syndrome after Oocyte Donation: a French multicenter retrospective study
Presenter: N. Chevalier
|
| |
|
|
|
08:50 10:20
|
|
Oral Communication 4
Eduard Flipse Hall
Chairs: V. Pirags (latvia) & R. Elisei (Italy)
|
| 08:50 |
OC4.1
|
Obestatin improves in vitro generation of novel insulin and glucagon secreting islet-like cell clusters from islet-derived non differentiated cells.
Presenter: A Baragli
|
| 09:05 |
OC4.2
|
Hepatic insulin resistance in rats on free-choice high-fat diets
Presenter: C Diepenbroek
|
| 09:20 |
OC4.3
|
Association of genetic polymorphisms in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein with the metformin intolerance and weight lowering in patients of type 2 diabetes
Presenter: J Klovins
|
| 09:35 |
OC4.4
|
HLA-G Polymorphism and Papillary Thyroid Cancer Histological Aggressiveness
Presenter: A Dardano
|
| 09:50 |
OC4.5
|
Comparison of four strategies of radioiodine ablation in patients with thyroid cancer with low-risk of recurrence: the randomized, prospective ESTIMABL study
Presenter: L Leenhardt
|
| 10:05 |
OC4.6
|
No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study
Presenter: G. Effraimidis
|
| |
|
|
|
08:50 10:20
|
|
Oral Communication 5
Fortis Bank Hall
Chairs: R. Nogueiras (Spain) & W. Arlt (UK)
|
| 08:50 |
OC5.1
|
HDL receptor SR-BI dysfunction is associated with a diminished adrenal glucocorticoid output in mice and man
Presenter: M Hoekstra
|
| 09:05 |
OC5.2
|
Site specific overexpression of Urocortin 2 results in modulation of steroidogenesis in vivo
Presenter: A Spyroglou
|
| 09:20 |
OC5.3
|
Identification of melanocortin 2 receptor structures responsible for specific membrane expression and ACTH binding specificity
Presenter: J Klovins
|
| 09:35 |
OC5.4
|
Adrenal melanocortin 2 receptor associated protein (MRAP) expression is regulated by ACTH and angiotensin II, whereas MRAP2 levels are associated with ACTH responsiveness
Presenter: J Hofland
|
| 09:50 |
OC5.5
|
The effect of MCT8 on the biological activity of T3
Presenter: A.A.A. van Mullem
|
| 10:05 |
OC5.6
|
A novel non-radioactive assay detects PTU-sensitive enzymatic deiodination of natural and synthetic iodinated compounds
Presenter: K Renko
|
| |
|
|
|
10:20 10:45
|
|
Coffee Break & Exhibition
Exhibition Hall
|
| |
|
|
|
10:45 12:15
|
|
Symposium 20: Thyroid function: it is in your genes
Main Auditorium
Chairs: H. Krude (Germany) & R. Paschke (Germany)
|
| 10:45 |
S20.1
|
Genetics versus Environment - what determines thyroid function?
P. Hansen (Denmark )
|
| 11:15 |
S20.2
|
Polymorphic variation in thyroid pathways genese
R. Peeters (NL)
|
| 11:45 |
S20.3
|
Genetic of autoimmune thyroid disease
M. Simmonds (UK )
|
| |
|
|
|
10:45 12:15
|
|
Symposium 21: Vitamin D, pregnancy and development
Willem Burger Auditorium
Chairs: Z. Hochberg (Israel) & TBC
|
| 10:45 |
S21.1
|
Evolutionary Perspective in vitamin D and its receptor VDR
Z. Hochberg (Israel )
|
| 11:15 |
S21.2
|
Vitamin D deficiency and supplementation in pregnancy
P. Lips (NL )
|
| 11:45 |
S21.3
|
Maternal vitamin D intake and risk of type-1 diabtes in offspring
S. Virtanen (Finland )
|
| |
|
|
|
10:45 12:15
|
|
Symposium 22: Non traditional effects of pituitary hormones
Jurriaanse Auditorium
Chairs: V. Popovic-Brkic (Serbia) & F. Kelestimur (Turkey)
|
| 10:45 |
S22.1
|
Non thyroidal effects of TSH
G. Williams (UK )
|
| 11:15 |
S22.2
|
Vasopressin and social odour processing in the olfactory system
M. Ludwig (UK )
|
| 11:45 |
S22.3
|
Prolactin, stem cells and prostate cancer
V. Goffin (France )
|
| |
|
|
|
12:15 13:00
|
|
Lunch & Exhibition
Exhibition Hall
|
| |
|
|
|
13:00 13:45
|
|
Meet the Expert 1 (REPEATED)
Willem Burger Auditorium
|
| 13:00 |
MTE1
|
Pros and cons of bariatric surgery
J. Salvador (Spain)
|
| |
|
|
|
13:00 13:45
|
|
Meet the Expert 2(REPEATED)
Jurriaanse Auditorium
|
| 13:00 |
MTE2
|
Primary hyperaldosteronism
M.Stowasser (Australia)
|
| |
|
|
|
13:00 13:45
|
|
Meet the Expert 3: (REPEATED)
Fortis Bank Hall
|
| 13:00 |
MTE3
|
Difficult recurrences and metastasis of thyroid cancer
L. Leenhardt (France)
|
| |
|
|
|
13:00 13:45
|
|
Meet the Expert 4 (REPEATED)
Van Ruckevorsal Hall
|
| 13:00 |
MTE4
|
Mass spectrometry in the measurement of hormones
U. Pagotto (Italy)
|
| |
|
|
|
13:00 13:45
|
|
Meet the Expert 5 (REPEATED)
Van der Vorm Hall
|
| 13:00 |
MTE5
|
How to write a manuscript - Meet the Editor
C. Strasburger (Germany)
|
| |
|
|
|
13:50 14:35
|
|
Meet the Expert 17
Willem Burger Auditorium
|
| 13:50 |
MTE17
|
Management of Phaeochromocytomas and paragangliomas
P-F. Plouin (France)
|
| |
|
|
|
13:50 14:35
|
|
Meet the Expert 7 (REPEATED)
Jurriaanse Auditorium
|
| 13:50 |
MTE7
|
When to instigate insulin therapy in DM2
J. Skrha (Czech Republic)
|
| |
|
|
|
13:50 14:35
|
|
Meet the Expert 8 (REPEATED)
Fortis Bank Hall
|
| 13:50 |
MTE8
|
Management of primary ovarian failure
L. Persani (Italy)
|
| |
|
|
|
13:50 14:35
|
|
Meet the Expert 9 (REPEATED)
Eduard Flipse Hall
|
| 13:50 |
MTE9
|
Pleiotropic effects of Vitamin D
M. Pfeifer (Slovenia)
|
| |
|
|
|
13:50 14:35
|
|
Meet the Expert 10 (REPEATED)
Van Ruckevorsal Hall
|
| 13:50 |
MTE10
|
Biomarkers of thyroid malignancy
M. Sobrinho-Simoes (Portugal)
|
| |
|
|
|
13:50 14:35
|
|
Meet the Expert 11 (REPEATED)
Van der Vorm Hall
|
| 13:50 |
MTE11
|
Prolactin and breast tumorogesis: a novel concept of prolactin biology
P. Touraine (France)
|
| |
|
|
|
14:35 15:00
|
|
Coffee Break & Exhibition
Exhibition Hall
|
| |
|
|
|
15:00 16:30
|
|
Symposium 23: Optimising thyroid hormone replacement
Main Auditorium
Chairs: L. Fugazzola (Italy) & P. Laurberg (Denmark)
|
| 15:00 |
S23.1
|
Is there a place for combined T4 and T3 replacement therapy?
A. Weetman (UK )
|
| 15:30 |
S23.2
|
Thyroid dysfunction in the elderly
K. Boelaert (UK )
|
| 16:00 |
S23.3
|
Failure of thyroxine replacement to suppress TSH - what to do now?
J. Orgiazzi (France )
|
| |
|
|
|
15:00 16:30
|
|
Symposium 24: Management of phaechromocytoma
Willem Burger Auditorium
Chairs: M. Mannelli (Italy) & TBC
|
| 15:00 |
S24.1
|
Biochemical screening for phaechromocytoma using plasma free metanephrines: utility beyond diagnosis
G. Eisenhofer (Germany )
|
| 15:30 |
S24.2
|
Imaging of phaechromocytoma and paragangliomas
H. Timmers (NL )
|
| 16:00 |
S24.3
|
Surgical Therapy
B. Niederle (Austria )
|
| |
|
|
|
15:00 16:30
|
|
Symposium 25: GNAS locus: imprinting, animal models and human diseases
Jurriaanse Auditorium
Chairs: A. Tsatsoulis (Greece) & A. Barlier (France)
|
| 15:00 |
S25.1
|
Genomic imprinting of the GNAS locus
G. Kelsey (UK )
|
| 15:30 |
S25.2
|
Epigenetic defects at the GNAS locus and human diseases
G. Mantovani (Italy)
|
| 16:00 |
S25.3
|
Xlas, in vitro functions and possible physiological and pathogenetic role
A. Linglart (France )
|
| |
|
|
|
16:35 16:50
|
|
ESE Young Investigator Awards & Poster Prizes
Generously supported by Novartis
Main Auditorium
|
| |
|
|
|
16:55 17:40
|
|
Plenary Lecture 6
Main Auditorium
Chair: P. Bouchard
|
| 16:55 |
PL6
|
Neurosteroids as Regenerative Agents in Brain: Therapeutic Implications for Cognition and Neurodegenerative Disease
R. Brinton (USA )
|
| |
|
|
|
17:40 18:30
|
|
Poster Reception
Poster Halls
|
| |
|
|
|
18:30 20:00
|
|
Annual General Meeting of the European Society of Endocrinology (ESE)
Willem Burger Auditorium
|
| |
|
|
|
20:30
|
|
President's Dinner
Invitation Only
|
| |
|
|
| 4 May 2011
|
|
07:45 14:00
|
|
Registration
|
| |
|
|
|
08:00 09:30
|
|
Symposium 26: The role of plasma binding proteins in tissue hormone delivery
Fortis Bank Hall
Chairs: M. Pugeat (France) & P. Rodien (France)
|
| 08:00 |
S26.1
|
Sex Hormone-binding Globulin: Beyond Plasma Transport
G. Hammond (Canada)
|
| 08:30 |
S26.2
|
The role of IGFBPs in the tissue-specific actions of IGFs
J.M.P. Holly (UK)
|
| 09:00 |
S26.3
|
The role of TTR in tissue delivery of thyroid hormone
M. J. Saraiva (Portugal )
|
| |
|
|
|
08:00 09:30
|
|
Symposium 27: Breaking news in adrenal malignancy
Jurriaanse Auditorium
Chairs: B. Allolio (Denmark) & S. Tsagarakis (Greece)
|
| 08:00 |
S27.1
|
European Network for the Study of Adrenal Tumours: Adrenal Cancer Consortium (ENS@T-CANCER)
F. Beuschlein (Germany)
|
| 08:30 |
S27.2
|
Transcriptome analysis and microRNAs in adrenal tumours
P. Igaz (Hungary)
|
| 09:00 |
S27.3
|
Management of adrenocorticol carcinoma - what have we learnt from recent trials?
M. Fassnacht (Germany)
|
| |
|
|
|
08:00 09:30
|
|
Symposium 28: Polycystic ovary syndrome - Classification, genetics and therapy
Main Auditorium
Chairs: R. Pasquali (Italy) & E. Diamanti-Kandarakis (Greece)
|
| 08:00 |
S28.1
|
Phenotypes and environmental factors
E. Diamanti-Kandarakis (Greece)
|
| 08:30 |
S28.2
|
Genetics
S. Franks (UK)
|
| 09:00 |
S28.3
|
Treatment of infertility and prediction of success
B. Fauser (The Netherlands)
|
| |
|
|
|
08:00 09:30
|
|
From Fat to Sex - Young Endocrine Research Across Europe
Young Active Research (YAR) Symposium
Eduard Flipse Hall
Chairs: F. Moeller & S. Neggers (Germany)
|
| 08:05 |
YAR1
|
Does puberty begin with a Kiss?
A. Bentsen (Denmark)
|
| 08:30 |
YAR2
|
Development of a mouse model with PCOS
L. van Houten (The Netherlands)
|
| 08:45 |
YAR3
|
Somatic sex reprogramming by FOXL2 deletion
H. Uhlenhaut (Germany)
|
| 09:10 |
YAR4
|
Small animal PET/CT imaging reveals altered in vivo insulin function in BAT of obese mice
C. Quarta (Italy)
|
| |
|
|
|
09:35 10:20
|
|
Plenary Lecture 7
Main Auditorium
Chair: M. Simoni (Italy)
|
| 09:35 |
PL7
|
Androgen use and misuse: A 2011 view
D. Handelsman (Australia)
|
| |
|
|
|
10:20 10:45
|
|
Coffee Break & Exhibition
Exhibition Hall
|
| |
|
|
|
10:45 11:30
|
|
Meet the Expert 12 (REPEATED)
Willem Burger Auditorium
|
| 10:45 |
MTE12
|
Treatment of strategies for obesity
D. Micic (Serbia)
|
| |
|
|
|
10:45 11:30
|
|
Meet the Expert 13 (REPEATED)
Jurriaanse Auditorium
|
| 10:45 |
MTE13
|
SIADH
C. Thompson (Ireland)
|
| |
|
|
|
10:45 11:30
|
|
Meet the Expert 14 (REPEATED)
Fortis Bank Hall
|
| 10:45 |
MTE14
|
Graves’ Ophthalmopathy
W. Wiersinga (The Netherlands)
|
| |
|
|
|
10:45 11:30
|
|
Meet the Expert 15 (REPEATED)
Eduard Flipse Hall
|
| 10:45 |
MTE15
|
Cushing's
S. Webb (Spain)
|
| |
|
|
|
10:45 11:30
|
|
Meet the Expert 16 (REPEATED)
Van der Vorm Hall
|
| 10:45 |
MTE16
|
Endocrine care in HIV-infected patients
V. Rochira (Italy)
|
| |
|
|
|
11:35 12:20
|
|
Meet the Expert 17(REPEATED)
Willem Burger Auditorium
|
| 10:45 |
MTE17
|
Management of Phaeochromocytomas and paragangliomas
P-F. Plouin (France)
|
| |
|
|
|
11:35 12:20
|
|
Meet the Expert 18 (REPEATED)
Jurriaanse Auditorium
|
| 11:35 |
MTE18
|
Weird thyroid function tests
M. Gurnell (UK)
|
| |
|
|
|
11:35 12:20
|
|
Meet the Expert 19 (REPEATED)
Fortis Bank Hall
|
| 11:35 |
MTE19
|
Management of primary hyperparathyroidism
J. Bollerslev (Norway)
|
| |
|
|
|
11:35 12:20
|
|
Meet the Expert 20 (REPEATED)
Eduard Flipse Hall
|
| 11:35 |
MTE20
|
Glucocorticoid replacement therapy
K. Lovas (Norway)
|
| |
|
|
|
11:35 12:20
|
|
Meet the Expert 21 (REPEATED)
Van Ruckevorsal Hall
|
| 11:35 |
MTE21
|
To whom to offer genetic analysis in patients with pituitary adenoma
A. Beckers (Belgium)
|
| |
|
|
|
11:35 12:20
|
|
Meet the Expert 22 (REPEATED)
Van der Vorm Hall
|
| 11:35 |
MTE22
|
Diabetes and the genome. Any use for our patients?
A-M Wagner (Spain)
|
| |
|
|
|
12:25 13:10
|
|
Plenary Lecture 8
Main Auditorium
Chair: P. Lips
|
| 12:25 |
PL8
|
Genetics of bone disease
S. Ralston (UK)
|
| |
|
|
|
13:10 13:25
|
|
Farewell & Invitation to Florence
Main Auditorium
|
| |
|
|